| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Bicara Therapeutics Inc. | President and COO, Director | Common Stock | 194K | $3.49M | $18.05 | Nov 21, 2025 | Direct |
| Bicara Therapeutics Inc. | President and COO, Director | Stock Option (Right to Buy) | 149K | Nov 21, 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| BCAX | Bicara Therapeutics Inc. | Nov 21, 2025 | 4 | -$195K | 4 | Nov 25, 2025 | President and COO, Director |
| BCAX | Bicara Therapeutics Inc. | Oct 15, 2025 | 4 | -$197K | 4 | Oct 16, 2025 | President and COO, Director |
| BCAX | Bicara Therapeutics Inc. | Oct 6, 2025 | 8 | -$791K | 4 | Oct 8, 2025 | President and COO, Director |
| BCAX | Bicara Therapeutics Inc. | Sep 12, 2024 | 0 | $0 | 3 | Sep 12, 2024 | President and COO |